Christopher Jenks

Dr. Christopher Jenks


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JFJordana Fox
Jordana Fox
CJChristopher Jenks
Christopher Jenks
AFAbdelaziz Farhat
Abdelaziz Farhat
XLXilong Li
Xilong Li
YLYulun Liu
Yulun Liu
LRLakshmi Raman
Lakshmi Raman
The goal of this project was to evaluate if severity of electroencephalogram (EEG) during or shortly after being placed on extracorporeal membrane oxygenation (ECMO) would correlate with neuroimaging abnormalities, and if that could be used as an early indicator of neurologic injury. This was a retrospective chart review spanning November 2009 to May 2018. Patients who had an EEG recording during ECMO or within 48 hours after being decannulated (early group) or within 3 months of being on ECMO (late group) were included if they also had ECMO-related neuroimaging. In the early EEG group, severity of the EEG findings of mild, moderate, and severe EEG correlated to mild, moderate, and severe neuroimaging scores. Patients on venoarterial (VA) ECMO were noted to have higher EEG and neuroimaging severity; this was statistically significant. There was no association in the late EEG group to neuroimaging abnormalities. Our study highlights that EEG severity can be an early predictor for neuroimaging abnormalities that can be identified by computed tomography (CT) and or magnetic resonance imaging (MRI). This can provide guidance for both the medical team and families, allowing for a better understanding of overall prognosis.

19 April 2021 in ASAIO Journal
Verified
Journal Article
Closed access
CJChristopher Jenks
Christopher Jenks
LLLily M. Landry
Lily M. Landry
CGCarrie F. Garrison
Carrie F. Garrison
JCJoshua G. Campbell
Joshua G. Campbell
MWMary F. Weeks
Mary F. Weeks
JKJarrod D. Knudson
Jarrod D. Knudson
Extracorporeal membrane oxygenation (ECMO) in pediatrics has rapidly progressed in recent years; however, there continues to be considerable variation in anticoagulation practices. In 2016, we implemented a standardized anticoagulation protocol in effort to reduce clotting and bleeding complications. A single-center retrospective analysis of pediatric patients requiring ECMO between 2014 and 2018 was performed. One hundred one ECMO cases in 94 pediatric patients met eligibility criteria (preprotocol = 64 cases; postprotocol = 37 cases). Demographics, ECMO parameters, complications, laboratories, and blood product requirements were analyzed for differences between the two groups. There was a significant decrease in the incidence of hematologic (p < 0.022), neurologic (p < 0.001), and renal complications (p < 0.001) in the postprotocol era. Incidence of bleeding, cardiac/pulmonary complications, and circuit changes were similar between the groups. The postprotocol group required fewer transfusions of red blood cells and cryoprecipitate. Additionally, platelet counts and fibrinogen levels were maintained higher in the postprotocol era. In conclusion, implementation of a standardized anticoagulation protocol was associated with improved anticoagulation parameters and a decrease in hematologic and neurologic complications, coagulopathy, renal injury, and blood product administration. We attribute these findings to transitioning to anti-Xa as a measure of heparinization and maintaining higher platelet counts.

23 November 2020 in Indian Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
CJChristopher Jenks
Christopher Jenks
LRLakshmi Raman
Lakshmi Raman
ADArchana Dhar
Archana Dhar